Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
November, 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Ifeanyichukwu Ifechidere: DOAC Interference in Coagulation Tests – Are You Spotting It?
Ifeanyichukwu Ifechidere/LinkedIn
May 12, 2026, 14:46

Ifeanyichukwu Ifechidere: DOAC Interference in Coagulation Tests – Are You Spotting It?

Ifeanyichukwu Ifechidere, Specialist Biomedical Scientist at Sheffield Teaching Hospitals NHS Foundation Trust, shared a post on LinkedIn:

“That ‘positive’ lupus anticoagulant result… might not be real.

And if you don’t catch it, you could be part of a misdiagnosis.

Let me talk to you — the biomedical scientist reviewing that coag screen. You run a lupus anticoagulant panel.

dRVVT ratio? – Prolonged.

APTT-based test? – Also prolonged.

‘Positive for LA,’ right?

Not so fast.

Is the patient on a DOAC?

Because here’s what many don’t realise:

Direct oral anticoagulants (DOACs) — especially factor Xa inhibitors and direct thrombin inhibitors — can significantly interfere with phospholipid-dependent assays.

And the result? – False positives in lupus anticoagulant testing

I’ve seen it happen:

  • Patients labelled as having antiphospholipid syndrome
  • Unnecessary long-term anticoagulation decisions
  • Clinical confusion…

All based on a misleading lab result

Here’s what should trigger your suspicion:

  • Unexpected LA positivity with no clinical history
  • Prolonged dRVVT and APTT in a patient on apixaban, rivaroxaban, or dabigatran
  • Inconsistent confirmatory testing patterns

Because DOACs can:

  • Prolong screening assays
  • Affect confirmatory steps
  • Mimic inhibitor patterns

And suddenly, your ‘LA positive’ isn’t a lupus anticoagulant at all…

It’s drug interference.

So before you validate that result, ask:

  • ‘Do I know the anticoagulation status of this patient?’
  • ‘Should this test have been performed while on a DOAC?’
  • – ‘Do we need DOAC-neutralisation or alternative strategies?’

Because in coagulation…

Context isn’t optional — it’s everything.

This is the level of thinking that separates running tests from truly understanding them.

If you want to get better at spotting interferences, interpreting complex results, and protecting patients from misleading data…

I break it down with real case studies Simple, practical interpretation frameworks. No jargon. Just clarity. Because not every abnormal result is pathology. Sometimes… it’s the test being fooled.”

Ifeanyichukwu Ifechidere

Other posts featuring Ifeanyichukwu Ifechidere on Hemostasis Today.

Antiphospholipid Syndrome Apixaban aPTT Blood dabigatran Direct thrombin inhibitors DOAC dRVVT Factor Xa Inhibitors Health Hematology Hemophilia Hemostasis Hemostasis News Hemostasis Today Ifeanyichukwu Ifechidere Lupus Anticoagulant Medicine Rivaroxaban
NewsFeed